TUESDAY, May 24, 2022 (HealthDay News) — COVID-19 can make a comeback after an infected person has gone through a round of Paxlovid, the antiviral used to minimize a bout with the coronavirus, according to an advisory issued Tuesday by the U.S. Centers for Disease Control and Prevention. “Recent caseContinue Reading
TUESDAY, May 24, 2022 (HealthDay News) — Cancer patients continue to face more risk from COVID-19, even if they’ve been vaccinated. Although vaccination is effective for most people who have cancer (even though they’re immunocompromised by the disease and their cancer treatments), its effectiveness wanes more rapidly in this group,Continue Reading
MONDAY, May 23, 2022 (HealthDay News) — Pfizer/BioNTech says a three-dose regimen of its COVID-19 vaccine appears to provoke a strong immune response in the youngest age group of children — those aged 6 months to 5 years. This is the only age group not yet approved for COVID-19 vaccinationContinue Reading
MONDAY, May 23, 2022 (HealthDay News) — COVID-19 might be easing into a new status as a widely circulating and somewhat harsher version of the common cold, experts say — a virus that folks could contract repeatedly, even if they were recently infected. “[SARS-CoV-2] is destined to join four ofContinue Reading
MONDAY, May 23, 2022 (HealthDay News) — The anti-inflammatory benefits of a common gout medicine may help save the lives of heart failure patients, researchers say. The medication, colchicine, could also reduce the risk of heart attack and stroke in patients whose arteries are clogged with cholesterol, according to theContinue Reading
MONDAY, May 23, 2022 (HealthDay News) — Organs from donors who died of drug overdoses helped keep the number of U.S. liver transplants steady during the first year of the COVID-19 pandemic, a new study finds. “When the pandemic began, we saw no decline in liver transplants, which seemed surprisingContinue Reading
THURSDAY, May 19, 2022 (HealthDay News) — A panel of science advisers to the U.S. Centers for Disease Control and Prevent recommended on Thursday that a single booster dose of the Pfizer COVID-19 vaccine can be given to 5- to 11-year-olds. The move is expected be confirmed by a sign-offContinue Reading
THURSDAY, May 19, 2022 (HealthDay News) — Getting a COVID-19 shot after you’ve been infected could reduce your risk of developing prolonged COVID symptoms, or so-called long COVID, according to a new study. “Our results suggest that vaccination of people previously infected may be associated with a reduction in theContinue Reading
WEDNESDAY, May 18, 2022 (HealthDay News) — If you have asthma or allergies, you may be more likely to develop heart disease, and some medications may increase or lower that risk, a new review of clinical trials and lab research shows. “Many people think of asthma as a disease ofContinue Reading
TUESDAY, May 17, 2022 (HealthDay News) — A single booster dose of the Pfizer COVID-19 vaccine can be given to 5- to 11-year-olds, the U.S. Food and Drug Administration announced today. The third shot can be given at least five months after healthy kids complete the two-dose vaccine series, theContinue Reading